New Study Assesses Cancer Risks with CT in Pediatric Patients
While one computed tomography (CT) scan appears to have no elevated cancer risk in pediatric patients, four or more pediatric exposures to CT scans are associated with increased risks for intracranial tumor, leukemia, and non-Hodgkin lymphoma, according to newly published research out of Taiwan.
Could Controlled Imaging Rein in Suboptimal Use of MRI, CT and Ultrasound Exams?
April 24th 2023Lamenting a lack of control over imaging requests from referring clinicians, this author suggests that a more collaborative approach between referrers and radiologists may facilitate more efficient use of imaging.
Emerging AI Tool Improves Worklist Triage and CT Detection of Incidental Pulmonary Embolism
In a new study involving over 11,700 chest computed tomography (CT) scans in oncology patients, adjunctive artificial intelligence software demonstrated a sensitivity rate of 91.6 percent for incidental pulmonary embolism (IPE) and reduced median detection and notification time for IPE-positive scans from multiple days to one hour for a radiology department at a comprehensive cancer center.
Should Race and Ethnicity Factor into Starting Ages for Mammography Screening?
Emerging research looking at data from over 414,000 cases of breast cancer deaths suggests that Black women should begin annual mammography screening seven to nine years earlier than White women.
Spine Radiology Insights on Venous Fistula Localization and Finding Cerebrospinal Fluid Leaks
In a recent lecture at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting, Andrew Callen, M.D., discussed a variety of imaging features associated with cerebrospinal fluid (CSF) leaks, the diagnostic utility of the Bern score as well as the merits of 3D T2FS MRI and dynamic computed tomography myelography.
Does Timing of Imaging Affect Interpretation of Contrast-Enhanced Mammography?
Earlier initiation of imaging after contrast administration with contrast-enhanced mammography may provide better visibility of lesions and conspicuity against background parenchymal enhancement, according to new research presented at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
RapidAI Gets FDA Nod for AI Assessment of Non-Contrast CT for Acute Stroke Triage
Powered by artificial intelligence (AI), the Rapid NCCT Stroke modality is reportedly the first medical device to gain FDA 510(k) clearance for detecting suspected large vessel occlusion and intracranial hemorrhage based on assessment of non-contrast computed tomography (NCCT).
Breast Reconstruction: Current Principles and Emerging Concepts in Imaging
Given the increasing prevalence of breast reconstruction, researchers discussed key signs of common complications on magnetic resonance imaging (MRI), ultrasound and other imaging during a recent presentation at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
Award-Winning Study Shows Benefits of 3D MRI for Assessing the Fetal Optic Pathway
Three-dimensional (3D) slice-to-volume (SVR) fetal magnetic resonance imaging (MRI) has over six times the fetal optic pathway visualization rate of standard two-dimensional MRI, according to new research presented at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
Recent research involving nearly 15,000 mammography exams in patients with a personal history of breast cancer revealed that digital breast tomosynthesis (DBT) was associated with a lower frequency of BI-RADS category 3 assessment and a lower malignancy rate for BI-RADS 3 lesions in comparison to full-field digital mammography.
What a Ten-Year CT Study Reveals About Emphysema and Continued Smoking
Over the course of a decade, people with preexisting emphysema who continued smoking had the greatest decline in lung density, according to computed tomography (CT) findings from a study involving over 8,400 total participants and over 4,100 current smokers.
Emerging Prostate and Brain MRI AI Platform Gets FDA Nod
In addition to a previously FDA-cleared brain magnetic resonance imaging (MRI) module, the Advantis Platform features an artificial intelligence-powered prostate MRI module that offers simultaneous viewing of conventional and advanced sequences, and reportedly generates automated PI-RADS assessments.